FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068700346> ?p ?o ?g. }

• W2068700346 endingPage "123" @default.
• W2068700346 startingPage "116" @default.
• W2068700346 abstract "Relapsed acute leukemia after allogeneic transplantation has a poor prognosis and most reports have focused on the role of second transplantations in relapsed patients. We report our single-institution experience on the management of relapsed acute leukemia after allogeneic transplantation. We aimed to describe the outcome of relapsed acute leukemia after allogeneic transplantation at our institution and investigate whether maneuvers intended to augment donor T cell allogeneic reactivity were associated with durable graft-versus-leukemia effects. We analyzed 310 patients with acute leukemia who received allogeneic hematopoietic progenitor cell transplants from HLA-matched donors between 1982 and 2005 (229 with acute myelogenous leukemia, 81 with acute lymphoblastic leukemia). Mean post-transplant follow-up was 5 years (range, 0.5-22 years). Factors associated with relapse incidence, therapy for relapse, response to treatment, and post-relapse survival were assessed. One hundred of 310 patients (32%) with acute leukemia relapsed after transplantation, including 28 of 81 patients (35%) with acute lymphoblastic leukemia and 72 of 229 (31%) with acute myelogenous leukemia at a median of 136 days after transplantation. Median post-relapse survival periods were 51 days for the 69 patients who received chemotherapy/supportive care, 84 days for 11 recipients of donor lymphocyte infusions, 303 days for 13 recipients of second transplants, and 442 days for 7 patients treated with interferon-alpha and granulocyte-macrophage colony-stimulating factor. A multivariable Cox regression analysis indicated that a longer time to relapse after transplantation, peripheral blood as source of stem cells, and initial post-relapse therapy with cytokines, donor lymphocyte infusions, or second transplants were associated with improved post-relapse survival (P <.001, <.001, and .025). The outlook for patients with post-transplant relapse of acute leukemia is extremely poor; currently, no single therapy consistently results in durable remissions. Our study highlights the need for clinical trials in this area. Therapy with granulocyte-macrophage colony stimulating factor and interferon-alpha-2b is promising and will be pursued in a prospective trial at our center." @default.
• W2068700346 created "2016-06-24" @default.
• W2068700346 creator A5011386306 @default.
• W2068700346 creator A5014892222 @default.
• W2068700346 creator A5052203408 @default.
• W2068700346 creator A5078031470 @default.
• W2068700346 creator A5082892912 @default.
• W2068700346 date "2007-01-01" @default.
• W2068700346 modified "2023-10-18" @default.
• W2068700346 title "Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience" @default.
• W2068700346 cites W1274344746 @default.
• W2068700346 cites W1492609361 @default.
• W2068700346 cites W1545991364 @default.
• W2068700346 cites W1707184873 @default.
• W2068700346 cites W1873141201 @default.
• W2068700346 cites W1961045948 @default.
• W2068700346 cites W1987513737 @default.
• W2068700346 cites W1996628620 @default.
• W2068700346 cites W2019326887 @default.
• W2068700346 cites W2022015347 @default.
• W2068700346 cites W2028397809 @default.
• W2068700346 cites W2028757734 @default.
• W2068700346 cites W2036116596 @default.
• W2068700346 cites W2044728051 @default.
• W2068700346 cites W2046478477 @default.
• W2068700346 cites W2049098874 @default.
• W2068700346 cites W2052463140 @default.
• W2068700346 cites W2053132434 @default.
• W2068700346 cites W2065470111 @default.
• W2068700346 cites W2075154508 @default.
• W2068700346 cites W2078590716 @default.
• W2068700346 cites W2082261439 @default.
• W2068700346 cites W2092257155 @default.
• W2068700346 cites W2097371321 @default.
• W2068700346 cites W2111779071 @default.
• W2068700346 cites W2148384019 @default.
• W2068700346 cites W2169401187 @default.
• W2068700346 cites W2246362970 @default.
• W2068700346 cites W2257559310 @default.
• W2068700346 cites W2297816245 @default.
• W2068700346 cites W2313760927 @default.
• W2068700346 cites W2316505355 @default.
• W2068700346 cites W2320180589 @default.
• W2068700346 cites W2322257489 @default.
• W2068700346 cites W2335166576 @default.
• W2068700346 cites W2340547456 @default.
• W2068700346 cites W2400663726 @default.
• W2068700346 cites W4210969505 @default.
• W2068700346 cites W4230048554 @default.
• W2068700346 cites W4254299890 @default.
• W2068700346 cites W593049771 @default.
• W2068700346 doi "https://doi.org/10.1016/j.bbmt.2006.09.005" @default.
• W2068700346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17222760" @default.
• W2068700346 hasPublicationYear "2007" @default.
• W2068700346 type Work @default.
• W2068700346 sameAs 2068700346 @default.
• W2068700346 citedByCount "85" @default.
• W2068700346 countsByYear W20687003462012 @default.
• W2068700346 countsByYear W20687003462013 @default.
• W2068700346 countsByYear W20687003462014 @default.
• W2068700346 countsByYear W20687003462015 @default.
• W2068700346 countsByYear W20687003462016 @default.
• W2068700346 countsByYear W20687003462017 @default.
• W2068700346 countsByYear W20687003462018 @default.
• W2068700346 countsByYear W20687003462019 @default.
• W2068700346 countsByYear W20687003462020 @default.
• W2068700346 countsByYear W20687003462021 @default.
• W2068700346 countsByYear W20687003462022 @default.
• W2068700346 countsByYear W20687003462023 @default.
• W2068700346 crossrefType "journal-article" @default.
• W2068700346 hasAuthorship W2068700346A5011386306 @default.
• W2068700346 hasAuthorship W2068700346A5014892222 @default.
• W2068700346 hasAuthorship W2068700346A5052203408 @default.
• W2068700346 hasAuthorship W2068700346A5078031470 @default.
• W2068700346 hasAuthorship W2068700346A5082892912 @default.
• W2068700346 hasBestOaLocation W20687003461 @default.
• W2068700346 hasConcept C126322002 @default.
• W2068700346 hasConcept C141071460 @default.
• W2068700346 hasConcept C143998085 @default.
• W2068700346 hasConcept C203014093 @default.
• W2068700346 hasConcept C2776863199 @default.
• W2068700346 hasConcept C2777408962 @default.
• W2068700346 hasConcept C2778461978 @default.
• W2068700346 hasConcept C2779695342 @default.
• W2068700346 hasConcept C2781107101 @default.
• W2068700346 hasConcept C2909962599 @default.
• W2068700346 hasConcept C2911091166 @default.
• W2068700346 hasConcept C71924100 @default.
• W2068700346 hasConceptScore W2068700346C126322002 @default.
• W2068700346 hasConceptScore W2068700346C141071460 @default.
• W2068700346 hasConceptScore W2068700346C143998085 @default.
• W2068700346 hasConceptScore W2068700346C203014093 @default.
• W2068700346 hasConceptScore W2068700346C2776863199 @default.
• W2068700346 hasConceptScore W2068700346C2777408962 @default.
• W2068700346 hasConceptScore W2068700346C2778461978 @default.
• W2068700346 hasConceptScore W2068700346C2779695342 @default.
• W2068700346 hasConceptScore W2068700346C2781107101 @default.
• W2068700346 hasConceptScore W2068700346C2909962599 @default.

• next